Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Feldman, H. A.
Right arrow Articles by McKinlay, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feldman, H. A.
Right arrow Articles by McKinlay, J. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 1 : 79-89
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study

Henry A. Feldman1, Catherine B. Johannes1, Andre B. Araujo1, Beth A. Mohr1, Christopher Longcope2 and John B. McKinlay1

1 New England Research Institutes, Watertown, MA.
2 University of Massachusetts Medical School, Worcester, MA.

The adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) have been characterized as "protective" against ischemic heart disease (IHD), especially in men, on the basis of sparse epidemiologic evidence. The authors used data from the Massachusetts Male Aging Study, a random sample prospective study of 1,709 men aged 40–70 years at baseline, to test whether serum levels of DHEA or DHEAS could predict incident IHD over a 9-year interval. At baseline (1987–1989) and follow-up (1995–1997), an interviewer-phlebotomist visited each subject in his home to obtain comprehensive health information, body measurements, and blood samples for hormone and lipid analysis. Incident IHD between baseline and follow-up was ascertained from hospital records and death registries, supplemented by self-report and evidence of medication. In the analysis sample of 1,167 men, those with serum DHEAS in the lowest quartile at baseline (<1.6 µg/ml) were significantly more likely to incur IHD by follow-up (adjusted odds ratio = 1.60, 95 percent confidence interval: 1.07, 2.39; p = 0.02), independently of a comprehensive set of known risk factors including age, obesity, diabetes, hypertension, smoking, serum lipids, alcohol intake, and physical activity. Low serum DHEA was similarly predictive. These results confirm prior evidence that low DHEA and DHEAS can predict IHD in men.

aging; androgens; cardiovascular diseases; coronary disease; dehydroepiandrosterone sulfate; myocardial ischemia; risk factors

Abbreviations: CI, confidence interval; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulfate; IHD, ischemic heart disease; OR, odds ratio.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. Haring, H. Volzke, S. B. Felix, S. Schipf, M. Dorr, D. Rosskopf, M. Nauck, C. Schofl, and H. Wallaschofski
Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men: Results From the Study of Health in Pomerania
Diabetes, September 1, 2009; 58(9): 2027 - 2031.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. G Cumming, D. Handelsman, M. J Seibel, H. Creasey, P. Sambrook, L. Waite, V. Naganathan, D. Le Couteur, and M. Litchfield
Cohort Profile: The Concord Health and Ageing in Men Project (CHAMP)
Int. J. Epidemiol., April 1, 2009; 38(2): 374 - 378.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Peter, A. Kelley-Hedgepeth, C. S. Fox, L. Adrienne Cupples, G. S. Huggins, D. E. Housman, R. H. Karas, M. E. Mendelsohn, D. Levy, and J. M. Murabito
Variation in Estrogen-Related Genes Associated with Cardiovascular Phenotypes and Circulating Estradiol, Testosterone, and Dehydroepiandrosterone Sulfate Levels
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2779 - 2785.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Fukui, H. Ose, I. Nakayama, H. Hosoda, M. Asano, M. Kadono, S.-i. Mogami, G. Hasegawa, T. Yoshikawa, and N. Nakamura
Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentrations in Women With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1886 - 1888.
[Full Text] [PDF]


Home page
CirculationHome page
E. A. Jankowska, B. Biel, J. Majda, A. Szklarska, M. Lopuszanska, M. Medras, S. D. Anker, W. Banasiak, P. A. Poole-Wilson, and P. Ponikowski
Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival
Circulation, October 24, 2006; 114(17): 1829 - 1837.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Arnlov, M. J. Pencina, S. Amin, B.-H. Nam, E. J. Benjamin, J. M. Murabito, T. J. Wang, P. E. Knapp, R. B. D'Agostino Sr., S. Bhasin, et al.
Endogenous sex hormones and cardiovascular disease incidence in men.
Ann Intern Med, August 1, 2006; 145(3): 176 - 184.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Kaufman and A. Vermeulen
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Endocr. Rev., October 1, 2005; 26(6): 833 - 876.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. S. Ford and S. Liu
Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life?
Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Makinen, M. J. Jarvisalo, P. Pollanen, A. Perheentupa, K. Irjala, M. Koskenvuo, J. Makinen, I. Huhtaniemi, and O. T. Raitakari
Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1603 - 1608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Bjornerem, B. Straume, M. Midtby, V. Fonnebo, J. Sundsfjord, J. Svartberg, G. Acharya, P. Oian, and G. K. R. Berntsen
Endogenous Sex Hormones in Relation to Age, Sex, Lifestyle Factors, and Chronic Diseases in a General Population: The Tromso Study
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6039 - 6047.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, G. Hasegawa, and T. Yoshikawa
Association Between Urinary Albumin Excretion and Serum Dehydroepiandrosterone Sulfate Concentration in Male Patients With Type 2 Diabetes: A possible link between urinary albumin excretion and cardiovascular disease
Diabetes Care, December 1, 2004; 27(12): 2893 - 2897.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee
Endogenous Sex Hormones and Cardiovascular Disease in Men
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
K. K. Dhatariya and K. S. Nair
Dehydroepiandrosterone: Is There a Role for Replacement?
Mayo Clin. Proc., October 1, 2003; 78(10): 1257 - 1273.
[Abstract] [PDF]


Home page
Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. A. Feldman, C. Longcope, C. A. Derby, C. B. Johannes, A. B. Araujo, A. D. Coviello, W. J. Bremner, and J. B. McKinlay
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 589 - 598.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.